Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers.

Tsuyoshi OzawaYojiro HashiguchiTakahiro YagiYoshihisa FukushimaRyu ShimadaTamuro HayamaTakeshi TsuchiyaKeijiro NozawaHisae IinumaSoichiro IshiharaKeiji Matsuda

Published in: International journal of colorectal disease (2019)

ACEI/ARB treatment may reduce tumor recurrence in left-sided CRC and early-stage CRC.

Keyphrases

angiotensin ii
angiotensin converting enzyme
early stage
vascular smooth muscle cells
free survival
radiation therapy